🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This was a single-arm, multicenter, Phase 2 study to evaluate the efficacy ...
Status
Unknown
Location
Shanghai Changzheng Hospital
Start Date
2023-08-01
Trial ID
NCT05979948
Treatments Being Tested
The goal of this phase II randomized open label study is to compare the rat...
Status
Recruiting
Location
H. General Univ. de Alicante
Start Date
2024-09-02
Trial ID
NCT06544785
Treatments Being Tested
This study is a single-arm, open label, non-randomized, phase 2 trial of za...
Status
Recruiting
Location
Virginia Commonwealth University
Start Date
2025-05-27
Trial ID
NCT06846463
Treatments Being Tested
This is a single-arm, open-label study of sonrotoclax plus zanubrutinib wit...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-05-30
Trial ID
NCT06367374
Treatments Being Tested
This is a prospective, single center, single arm, open label study of zanub...
Status
Unknown
Location
Renji Hospital, Shanghai Jiaotong University School of Medicine
Start Date
2023-10-12
Trial ID
NCT06033820
Treatments Being Tested
The purpose of this study is to determine the very good partial response (V...
Status
Recruiting
Location
Colorado Blood Cancer Institute (CBCI)
Start Date
2024-12-20
Trial ID
NCT06561347
Treatments Being Tested
Zanubrutinib, as a new generation of BTK inhibitors, has shown more potent ...
Status
Not Yet Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2025-06-01
Trial ID
NCT06890585
This phase I clinical study was to investigate the safety, tolerability, an...
Status
Completed
Location
Beijing Cancer Hospital
Start Date
2016-07-05
Trial ID
NCT03189524
Treatments Being Tested
The goal of this observational study is to comprehensively profile six immu...
Status
Recruiting
Location
Radboud University Medical Center
Start Date
2025-07-29
Trial ID
NCT07021495
The primary objective of this study is to determine the maximum tolerated d...
Status
Completed
Location
Beijing Friendship Hospital, Capital Medical University
Start Date
2020-09-11
Trial ID
NCT04436107
Treatments Being Tested